Pharmacological therapy for patients with abdominal aortic aneurysm

References

• Thompson RW, Curci JA, Ennis TL, Mao D, Pagano MB, Pham CTN. Pathophysiology of abdominal aortic aneurysms: insights from the elastase-induced model in mice with different genetic backgrounds. Ann. NY Acad. Sci.1085, 59–73 (2006).
   PubMed Web of Science ®Google Scholar
• Lederle FA, Johnson GR, Wilson SE et al. Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. Ann. Intern. Med.126(6), 441–449 (1997).
   PubMed Web of Science ®Google Scholar
• Ruddy JM, Jones JA, Spinale FG, Ikonomidis JS. Regional heterogeneity within the aorta: relevance to aneurysm disease. J. Thorac. Cardiovasc. Surg.136(5), 1123–1130 (2008).
   PubMed Web of Science ®Google Scholar
• Pearce WH, Zarins CK, Bacharach JM. Writing Group for Atherosclerotic Peripheral Vascular Disease Symposium II: controversies in abdominal aortic aneurysm repair. Circulation118(25), 2860–2863 (2008).
   PubMed Web of Science ®Google Scholar
• The UK Small Aneurysm Trial Participants. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet352(9141), 1649–1655 (1998).
   PubMed Web of Science ®Google Scholar
• Lederle FA, Wilson SE, Johnson GR et al. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N. Engl. J. Med.346(19), 1437–1444 (2002).
   PubMed Web of Science ®Google Scholar
• Ashton HA, Buxton MJ, Day NE et al. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet360(9345), 1531–1539 (2002).
   PubMed Web of Science ®Google Scholar
• Lindholt JS, Juul S, Fasting H, Henneberg EW. Screening for abdominal aortic aneurysms: single centre randomised controlled trial. BMJ330(7494), 750 (2005).
   PubMed Web of Science ®Google Scholar
• Cosford PA, Leng GC. Screening for abdominal aortic aneurysm. Cochrane Database Syst. Rev.2, CD002945 (2007).
   Google Scholar
• Screening for abdominal aortic aneurysm: recommendation statement. Ann. Intern. Med.142(3), 198–202 (2005).
   PubMed Web of Science ®Google Scholar
• Fleming C, Whitlock EP, Beil TL, Lederle FA. Screening for abdominal aortic aneurysm: a best-evidence systematic review for the U.S. Preventive Services Task Force. Ann. Intern. Med.142(3), 203–211 (2005).
   PubMed Web of Science ®Google Scholar
• Boll AP, Verbeek AL, van de Lisdonk EH, van der Vliet JA. High prevalence of abdominal aortic aneurysm in a primary care screening programme. Br. J. Surg.85(8), 1090–1094 (1998).
   PubMed Web of Science ®Google Scholar
• Norman P, Le M, Pearce C, Jamrozik K. Infrarenal aortic diameter predicts all-cause mortality. Arterioscler. Thromb. Vasc. Biol.24(7), 1278–1282 (2004).
   PubMed Web of Science ®Google Scholar
• Brady AR, Fowkes FG, Thompson SG, Powell JT. Aortic aneurysm diameter and risk of cardiovascular mortality. Arterioscler. Thromb. Vasc. Biol.21(7), 1203–1207 (2001).
   PubMed Web of Science ®Google Scholar
• Lindholt JS, Vammen S, Fasting H, Henneberg EW. Psychological consequences of screening for abdominal aortic aneurysm and conservative treatment of small abdominal aortic aneurysms. Eur. J. Vasc. Endovasc. Surg.20(1), 79–83 (2000).
   PubMed Web of Science ®Google Scholar
• Zarins CK, Crabtree T, Arko FR et al. Endovascular repair or surveillance of patients with small AAA. Eur. J. Vasc. Endovasc. Surg.29(5), 496–503 (2005).
   PubMed Web of Science ®Google Scholar
• Greenhalgh RM, Brown LC, Kwong GPS, Powell JT, Thompson SG. Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial. Lancet364(9437), 843–848 (2004).
   PubMed Web of Science ®Google Scholar
• Prinssen M, Verhoeven ELG, Buth J et al. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N. Engl. J. Med.351(16), 1607–1618 (2004).
   PubMed Web of Science ®Google Scholar
• Cao P. Comparison of surveillance vs Aortic Endografting for Small Aneurysm Repair (CAESAR) trial: study design and progress. Eur. J. Vasc. Endovasc. Surg.30(3), 245–251 (2005).
   PubMed Web of Science ®Google Scholar
• Ouriel K. The PIVOTAL study: a randomized comparison of endovascular repair versus surveillance in patients with smaller abdominal aortic aneurysms. J. Vasc. Surg.49(1), 266–269 (2009).
   PubMed Web of Science ®Google Scholar
• Bertges DJ, Zwolak RM, Deaton DH et al. Current hospital costs and medicare reimbursement for endovascular abdominal aortic aneurysm repair. J. Vasc. Surg.37(2), 272–279 (2003).
   PubMed Web of Science ®Google Scholar
• Back MR. Surveillance after endovascular abdominal aortic aneurysm repair. Perspect. Vasc. Surg. Endovasc. Ther.19(4), 395–400 (2007).
   PubMedGoogle Scholar
• Rentschler M, Baxter BT. Pharmacological approaches to prevent abdominal aortic aneurysm enlargement and rupture. Ann. NY Acad. Sci.1085, 39–46 (2006).
   PubMed Web of Science ®Google Scholar
• Kuivaniemi H, Platsoucas CD, Tilson MD III. Aortic aneurysms: an immune disease with a strong genetic component. Circulation117(2), 242–252 (2008).
   PubMed Web of Science ®Google Scholar
• Wassef M, Upchurch GR, Kuivaniemi H, Thompson RW, Tilson MD III. Challenges and opurtunities in abdominal aortic aneurysm research. J. Vasc. Surg.45(1), 192–198 (2007).
   PubMed Web of Science ®Google Scholar
• Shimizu K, Nitchell RN, Libby P. Inflammation and cellular immune responses in abdominal aortic aneurysms. Aterioscler. Thromb. Vasc. Biol.26(5), 987–994 (2006).
   PubMed Web of Science ®Google Scholar
• Curci JA, Thompson RW. Adaptive cellular immunity in aortic aneurysms: cause, consequence, or context? J. Clin. Invest.114(2), 168–171 (2004).
   PubMed Web of Science ®Google Scholar
• Choke E, Cockerill GW, Laing K et al. Whole genome-expression profiling reveals a role for immune and inflammatory response in abdominal aortic aneurysm rupture. Eur. J. Vasc. Endovasc. Surg.37(3), 305–310 (2009).
   PubMed Web of Science ®Google Scholar
• Aoki H, Yoshimura K, Matsuzaki M. Turning back the clock: regression of abdominal aortic aneurysms via pharmacotherapy. J. Mol. Med.85(10), 1077–1088 (2007).
   PubMed Web of Science ®Google Scholar
• Jagadesham VP, Scott JA, Carding SR. Abdominal aortic aneurysms: an autoimmune disease? Trends Mol. Med.14(12), 522–529 (2008).
   PubMed Web of Science ®Google Scholar
• Schillinger M, Domanovits H, Ignatescu M et al. Lipoprotein (a) in patients with aortic aneurysmal disease. J. Vasc. Surg.36(1), 25–30 (2002).
   PubMed Web of Science ®Google Scholar
• Dalman RL. Oxidative stress and abdominal aneurysms: how aortic hemodynamic conditions may influence AAA disease. Cardiovasc. Surg.11(5), 417–419 (2003).
   PubMedGoogle Scholar
• Lindholt JS, Støvring J, Østergaard L et al. Serum antibodies against Chlamydia pneumoniae outer membrane protein cross-react with the heavy chain of immunoglobulin in the wall of abdominal aortic aneurysms. Circulation109(17), 2097–2102 (2004).
   PubMed Web of Science ®Google Scholar
• Daugherty A, Cassis L. Angiotensin II and abdominal aortic aneurysms. Curr. Hypertens. Rep.6(6), 442–446 (2004).
   PubMed Web of Science ®Google Scholar
• Lu H, Rateri DL, Cassis LA, Daugherty A. The role of the renin–angiotensin system in aortic aneurysmal diseases. Curr. Hypertens. Rep.10(2), 99–106 (2008).
   PubMed Web of Science ®Google Scholar
• Dobrin PB, Baker WH, Gley WC. Elastolytic and collagenolytic studies of arteries. Implications for the mechanical properties of aneurysms. Arch. Surg.119(4), 405–409 (1984).
   PubMed Web of Science ®Google Scholar
• Hobeika MJ, Thompson RW, Muhs BE, Brooks PC, Gagne PJ. Matrix metalloproteinases in peripheral vascular disease. J. Vasc. Surg.45(4), 849–857 (2007).
   PubMed Web of Science ®Google Scholar
• Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol.15(8), 1145–1151 (1995).
   PubMed Web of Science ®Google Scholar
• Longo GM, Xiong W, Greiner TC et al. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J. Clin. Invest.110(5), 625–632 (2002).
   PubMed Web of Science ®Google Scholar
• Petersen E, Wågberg F, Angquist KA. Proteolysis of the abdominal aortic aneurysm wall and the association with rupture. Eur. J. Vasc. Endovasc. Surg.23(2), 153–157 (2002).
   PubMed Web of Science ®Google Scholar
• Wilson WRW, Anderton M, Schwalbe EC et al. Matrix metalloproteinase-8 and -9 are increased at the site of abdominal aortic aneurysm rupture. Circulation113(3), 438–445 (2006).
   PubMed Web of Science ®Google Scholar
• Pyo R, Lee JK, Shipley JM et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J. Clin. Invest.105(11), 1641–1649 (2000).
   PubMed Web of Science ®Google Scholar
• Golledge J, Powell JT. Medical management of abdominal aortic aneurysm. Eur. J. Vasc. Endovasc. Surg.34(3), 267–273 (2007).
   PubMed Web of Science ®Google Scholar
• Baumgartner I, Hirsch AT, Abola MTB et al. Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry. J. Vasc. Surg.48(4), 808–814 (2008).
   PubMed Web of Science ®Google Scholar
• Lederle FA, Nelson DB, Joseph AM. Smokers’ relative risk for aortic aneurysm compared with other smoking-related diseases: a systematic review. J. Vasc. Surg.38(2), 329–334 (2003).
   PubMed Web of Science ®Google Scholar
• Brady AR, Thompson SG, Fowkes FGR, Greenhalgh RM, Powell JT. Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation110(1), 16–21 (2004).
   PubMed Web of Science ®Google Scholar
• Kakafika AI, Mikhailidis DP. Smoking and aortic diseases. Circ. J.71(8), 1173–1180 (2007).
   PubMed Web of Science ®Google Scholar
• Mochida-Nishimura K, Surewicz K, Cross JV et al. Differential activation of MAP kinase signaling pathways and nuclear factor-κB in bronchoalveolar cells of smokers and nonsmokers. Mol. Med.7(3), 177–185 (2001).
   PubMed Web of Science ®Google Scholar
• Lindholt JS. Activators of plasminogen and the progression of small abdominal aortic aneurysms. Ann. NY Acad. Sci.1085, 139–150 (2006).
   PubMed Web of Science ®Google Scholar
• Bergoeing MP, Arif B, Hackmann AE, Ennis TL, Thompson RW, Curci JA. Cigarette smoking increases aortic dilatation without affecting matrix metalloproteinase-9 and-12 expression in a modified mouse model of aneurysm formation. J. Vasc. Surg.45(6), 1217–1227 (2007).
   PubMed Web of Science ®Google Scholar
• Baxter BT, Terrin MC, Dalman RL. Medical management of small abdominal aortic aneurysms. Circulation117(14), 1883–1889 (2008).
   PubMed Web of Science ®Google Scholar
• Kuivaniemi H, Shibamura H, Arthur C et al. Familial abdominal aortic aneurysms: collection of 233 multiplex families. J. Vasc. Surg.37(2), 340–345 (2003).
   PubMed Web of Science ®Google Scholar
• Kuivaniemi H, Kyo Y, Lenk G, Tromp G. Genome-wide approach to finding abdominal aortic aneurysm susceptibility genes in humans. Ann. NY Acad. Sci.1085, 270–281 (2006).
   PubMed Web of Science ®Google Scholar
• Sandford RM, Bown MJ, London NJ, Sayers RD. The genetic basis of abdominal aortic aneurysms: a review. Eur. J. Vasc. Endovasc. Surg.33(4), 381–390 (2007).
   PubMed Web of Science ®Google Scholar
• Shibamura H, Olson JM, van Vlijmen-Van Keulen C et al. Genome scan for familial abdominal aortic aneurysm using sex and family history as covariates suggests genetic heterogeneity and identifies linkage to chromosome 19q13. Circulation109(17), 2103–2108 (2004).
   PubMed Web of Science ®Google Scholar
• Norman PE, Davis TM, Le MT, Golledge J. Matrix biology of abdominal aortic aneurysms in diabetes: mechanisms underlying the negative association. Connect. Tissue Res.48(3), 125–131 (2007).
   PubMed Web of Science ®Google Scholar
• Norman P, Spencer CA, Lawrence-Brown MM, Jamrozik K. C-reactive protein levels and the expansion of screen-detected abdominal aortic aneurysms in men. Circulation110(7), 862–866 (2004).
   PubMed Web of Science ®Google Scholar
• Golledge J, Muller J, Daugherty A, Norman P. Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler. Thromb. Vasc. Biol.26(12), 2605–2613 (2006).
   PubMed Web of Science ®Google Scholar
• Slaiby JM, Ricci MA, Gadowski GR, Hendley ED, Pilcher DB. Expansion of aortic aneurysms is reduced by propranolol in a hypertensive rat model. J. Vasc. Surg.20(2), 178–183 (1994).
   PubMed Web of Science ®Google Scholar
• Brophy C, Tilson JE, Tilson MD. Propranolol delays the formation of aneurysms in the male blotchy mouse. J. Surg. Res.44(6), 687–689 (1988).
   PubMed Web of Science ®Google Scholar
• Steinmetz EF, Buckley C, Shames ML et al. Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice. Ann. Surg.241(1), 92–101 (2005).
   PubMed Web of Science ®Google Scholar
• Kalyanasundaram A, Elmore JR, Manazer JR et al. Simvastatin suppresses experimental aortic aneurysm expansion. J. Vasc. Surg.43(1), 117–124 (2006).
   PubMed Web of Science ®Google Scholar
• Manning MW, Cassis LA, Daugherty A. Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol.23(3), 483–488 (2003).
   PubMed Web of Science ®Google Scholar
• Petrinec D, Liao S, Holmes DR, Reilly JM, Parks WC, Thompson RW. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J. Vasc. Surg.23(2), 336–346 (1996).
   PubMed Web of Science ®Google Scholar
• Curci JA, Petrinec D, Liao S, Golub LM, Thompson RW. Pharmacologic suppression of experimental abdominal aortic aneurysms: a comparison of doxycycline and four chemically modified tetracyclines. J. Vasc. Surg.28(6), 1082–1093 (1998).
   PubMed Web of Science ®Google Scholar
• Lawrence DM, Singh RS, Franklin DP, Carey DJ, Elmore JR. Rapamycin suppresses experimental aortic aneurysm growth. J. Vasc. Surg.40(2), 334–338 (2004).
   PubMed Web of Science ®Google Scholar
• Liao S, Miralles M, Kelley BJ, Curci JA, Borhani M, Thompson RW. Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors. J. Vasc. Surg.33(5), 1057–1064 (2001).
   PubMed Web of Science ®Google Scholar
• Miralles M, Wester W, Sicard GA, Thompson R, Reilly JM. Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the COX-2 isoform of cyclooxygenase. J. Vasc. Surg.29(5), 884–892 (1999).
   PubMed Web of Science ®Google Scholar
• King VL, Trivedi DB, Gitlin JM, Loftin CD. Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice. Arterioscler. Thromb. Vasc. Biol.26(5), 1137–1143 (2006).
   PubMed Web of Science ®Google Scholar
• Ailawadi G, Eliason JL, Roelofs KJ et al. Gender differences in experimental aortic aneurysm formation. Arterioscler. Thromb. Vasc. Biol.24(11), 2116–2122 (2004).
   PubMed Web of Science ®Google Scholar
• Martin-McNulty B, Tham DM, da Cunha V et al. 17 β-estradiol attenuates development of angiotensin II-induced aortic abdominal aneurysm in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol.23(9), 1627–1632 (2003).
   PubMed Web of Science ®Google Scholar
• Bigatel DA, Elmore JR, Carey DJ, Cizmeci-Smith G, Franklin DP, Youkey JR. The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms. J. Vasc. Surg.29(1), 130–138 (1999).
   PubMed Web of Science ®Google Scholar
• Moore G, Liao S, Curci JA et al. Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908). J. Vasc. Surg.29(3), 522–532 (1999).
   PubMed Web of Science ®Google Scholar
• Armstrong PJ, Franklin DP, Carey DJ, Elmore JR. Suppression of experimental aortic aneurysms: comparison of inducible nitric oxide synthase and cyclooxygenase inhibitors. Ann. Vasc. Surg.19(2), 248–257 (2005).
   PubMed Web of Science ®Google Scholar
• Johanning JM, Franklin DP, Han DC, Carey DJ, Elmore JR. Inhibition of inducible nitric oxide synthase limits nitric oxide production and experimental aneurysm expansion. J. Vasc. Surg.33(3), 579–586 (2001).
   PubMed Web of Science ®Google Scholar
• Wang Y-X, Martin-McNulty B, da Cunha V et al. Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis. Circulation111(17), 2219–2226 (2005).
   PubMed Web of Science ®Google Scholar
• Gavrila D, Li WG, McCormick ML et al. Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol.25(8), 1671–1677 (2005).
   PubMed Web of Science ®Google Scholar
• Parodi FE, Mao D, Ennis TL, Bartoli MA, Thompson RW. Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate, an antioxidant inhibitor of nuclear factor-κB. J. Vasc. Surg.41(3), 479–489 (2005).
   PubMed Web of Science ®Google Scholar
• Grigoryants V, Hannawa KK, Pearce CG et al. Tamoxifen up-regulates catalase production, inhibits vessel wall neutrophil infiltration, and attenuates development of experimental abdominal aortic aneurysms. J. Vasc. Surg.41(1), 108–114 (2005).
   PubMed Web of Science ®Google Scholar
• Yoshimura K, Aoki H, Ikeda Y et al. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat. Med.11(12), 1330–1338 (2005).
   PubMed Web of Science ®Google Scholar
• Vammen S, Lindholt JS, Ostergaard L, Fasting H, Henneberg EW. Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion. Br. J. Surg.88(8), 1066–1072 (2001).
   PubMed Web of Science ®Google Scholar
• Mosorin M, Juvonen J, Biancari F et al. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. J. Vasc. Surg.34(4), 606–610 (2001).
   PubMed Web of Science ®Google Scholar
• Baxter BT, Pearce WH, Waltke EA et al. Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J. Vasc. Surg.36(1), 1–12 (2002).
   PubMed Web of Science ®Google Scholar
• Bellosta S, Bernini F. Modulation of macrophage function and metabolism. Handb. Exper. Pharmacol. (170), 665–695 (2005).
   PubMedGoogle Scholar
• Nagashima H, Aoka Y, Sakomura Y et al. A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall. J. Vasc. Surg.36(1), 158–163 (2002).
   PubMed Web of Science ®Google Scholar
• Evans J, Powell JT, Schwalbe E, Loftus IM, Thompson MM. Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue. Eur. J. Vasc. Endovasc. Surg.34(3), 302–303 (2007).
   PubMed Web of Science ®Google Scholar
• Sukhija R, Aronow WS, Sandhu R, Kakar P, Babu S. Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins. Am. J. Cardiol.97(2), 279–280 (2006).
   PubMed Web of Science ®Google Scholar
• Schouten O, van Laanen JHH, Boersma E et al. Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur. J. Vasc. Endovasc. Surg.32(1), 21–26 (2006).
   PubMed Web of Science ®Google Scholar
• Lindholt JS, Henneberg EW, Juul S, Fasting H. Impaired results of a randomised double blinded clinical trial of propranolol versus placebo on the expansion rate of small abdominal aortic aneurysms. Internat. Angiol.18(1), 52–57 (1999).
   PubMed Web of Science ®Google Scholar
• Propanolol Aneurysm Trial Investigators. Propranolol for small abdominal aortic aneurysms: results of a randomized trial. J. Vasc. Surg.35(1), 72–79 (2002).
   PubMed Web of Science ®Google Scholar
• Hackam DG, Thiruchelvam D, Redelmeier DA. Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case–control study. Lancet368(9536), 659–665 (2006).
   PubMed Web of Science ®Google Scholar
• Fleisher LA, Beckman JA, Brown KA et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J. Am. Coll. Cardiol.50(17), 1707–1732 (2007).
   PubMed Web of Science ®Google Scholar
• Devereaux PJ, Yang H, Yusuf S et al.; POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet371(9627), 1839–1847 (2008).
   PubMed Web of Science ®Google Scholar
• Kapoor AS, Kanji H, Buckingham J, Devereaux PJ, McAlister FA. Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies. BMJ333(7579), 1149 (2006).
   PubMed Web of Science ®Google Scholar
• Hackmann AE, Rubin BG, Sanchez LA, Geraghty PA, Thompson RW, Curci JA. A randomized, placebo-controlled trial of doxycycline after endoluminal aneurysm repair. J. Vasc. Surg.48(3), 519–526 (2008).
   PubMed Web of Science ®Google Scholar
• Kertai MD, Boersma E, Westerhout CM et al. Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am. J. Med.116(2), 96–103 (2004).
   PubMed Web of Science ®Google Scholar
• Leurs LJ, Visser P, Laheij RJF, Buth J, Harris PLH, Blankensteijn JD. Statin use is associated with reduced all-cause mortality after endovascular abdominal aortic aneurysm repair. Vascular14(1), 1–8 (2006).
   PubMed Web of Science ®Google Scholar
• Lloyd GM, Newton JD, Norwood MGA, Franks SC, Bown MJ, Sayers RD. Patients with abdominal aortic aneurysm: are we missing the opportunity for cardiovascular risk reduction? J. Vasc. Surg.40(4), 691–697 (2004).
   PubMed Web of Science ®Google Scholar